Genetics give investigators a risk stratification in glaucoma
November 15, 2021
PRS can modify disease outcomes due to other genes, such as MYOC.
© 2021 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
Glaucoma
MIGS with OMNI system linked with diminished diurnal IOP fluctuations, a risk factor for glaucoma progression
November 17, 2021
The 12-Month OMNI data from the prospective, multicenter GEMINI clinical trial show statistically significant postoperative reductions in mean IOP and suppression of daily IOP fluctuations.
Study: Bimatoprost implant reduces IOP for 2 years or more
November 13, 2021
Felipe Medeiros, MD, presents results from a phase 3 clinical extension study of the bimatoprost implant that found patients’ IOP was lowered and stayed low with no additional treatment or changes in their visual fiends.
POAAGG study targets gene therapy options for glaucoma
November 03, 2021
Investigators find that mutations could lead to early treatment intervention.
Advances in cataract surgery show value in tools, tech for surgeons
October 22, 2021
Three cases demonstrate value of new tools, technology for surgeons.
Aerie reports positive phase 3 results for netarsudil 0.02% vs ripasudil 0.4% in lowering IOP
October 12, 2021
Aerie Pharmaceuticals announced Tuesday positive topline results for the phase 3 trial evaluating netarsudil 0.02% versus ripasudil 0.4% for the treatment of open-angle glaucoma and elevated IOP.
Advances in cyclophotocoagulation: Good, better, best options outlined
October 11, 2021
Changes are resulting in better outcomes for patients with glaucoma.
Identifying the association between MIGS and endophthalmitis
October 10, 2021
Yoshihiro Yonekawa, MD, reports on the findings of an investigation looking at the prevalence of endophthalmitis following minimally invasive glaucoma surgery.
ViaLase CEO talks innovations in glaucoma treatment
September 21, 2021
Tibor Juhasz, CEO of ViaLase, Inc, discusses the company's development of a novel, noninvasive high-resolution OCT image-guided femtosecond laser technology for the treatment of open-angle glaucoma.
The path to faster visual recovery following glaucoma surgery
September 14, 2021
Speed the return to baseline visual acuity—and make your patients happy.